Aarkstore - Panic Disorders-Pipeline Insights, 2014

1
Fatty Liver Disease-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77314/-panic-d
  isorders-pipeline-insights-2014

2
Summary

• DelveInsights, Panic Disorders-Pipeline Insights,
  2014, report provides comprehensive insights
  about pipeline drugs across this indication. A
  key objective of the report is to establish the
  understanding for all the pipeline drugs that
  fall under Panic Disorders. This report provides
  information on the therapeutic development based
  on the Panic Disorders dealing with all the
  pipeline drugs, comparative analysis at various
  stages covering Filed, Phase III, Phase II, Phase
  I, IND filed, Preclinical, Discovery and unknown
  stages, therapeutics assessment by monotherapy
  and combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Panic DisordersThe
  report provides pipeline products under drug
  profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Panic Disorders
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Panic Disorders
  and also provide company profilingThe report
  also gives the information of dormant and
  discontinued pipeline projects Pipeline products
  coverage based on various stages of development
  ranging from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Panic DisordersIdentify the
  relationship between the drugs and use it for
  target finding, drug repurposing, and precision
  medicine.Devise corrective measures for pipeline
  projects by understanding Panic Disorders
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

7
Table of Content

• Panic Disorders OverviewPanic Disorders Pipeline
  TherapeuticsPanic Disorders Therapeutics under
  Development by Companies Panic Disorders Late
  Stage Products (Filed and Phase III)Comparative
  Analysis Panic Disorders Mid Clinical Stage
  Products (Phase II)Comparative Analysis Panic
  Disorders Early Clinical Stage Products (Phase I
  and IND Filed)Comparative Analysis Panic
  Disorders Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles

8
Table of Content

• Panic Disorders Therapeutics Assessment Assessmen
  t by Monotherapy Products Assessment by
  Combination Products Assessment by Route of
  Administration Assessment by Molecule
  Type Panic Disorders Discontinued
  Products Panic Disorders Dormant
  ProductsCompanies Involved in Therapeutics
  Development for Panic Disorders Appendix Methodo
  logy Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Panic
  Disorders, 2014Number of Products under
  Development by Companies Comparative Analysis by
  Late Clinical Stage Products (Filed and Phase
  III), 2014Comparative Analysis Mid Clinical
  Stage Products (Phase II), 2014Comparative
  Analysis Early Clinical Stage Products (Phase I
  and IND Filed), 2014Comparative Analysis
  Discovery and Pre-Clinical Stage Products,
  2014Drug Candidates ProfilesPanic Disorders
  Assessment by Monotherapy Products Panic
  Disorders Assessment by Combination
  Products Panic Disorders Assessment by Route of
  Administration 

10
List of Tables

• Panic Disorders Assessment by Stage and Route of
  Administration Panic Disorders Assessment by
  Molecule Type Panic Disorders Assessment by
  Stage and Molecule Type Panic Disorders
  Therapeutics Discontinued Products Panic
  Disorders Therapeutics Dormant ProductsProducts
  under Development by Companies, 2014

11
List of Figures

• Number of Products under Development for Panic
  Disorders, 2014Late Clinical Stage Products
  (Filed and Phase III), 2014Mid Clinical Stage
  Products (Phase II), 2014Early Clinical Stage
  Products (Phase I and IND Filed), 2014Discovery
  and Pre-Clinical Stage Products, 2014Panic
  Disorders Assessment by Monotherapy
  Products Panic Disorders Assessment by
  Combination Products Panic Disorders Assessment
  by Route of Administration Panic Disorders
  Assessment by Stage and Route of
  Administration Panic Disorders Assessment by
  Molecule Type Panic Disorders Assessment by
  Stage and Molecule Type

12
Related Reports

• The Mobile Healthcare (mHealth) Bible 2014 -
  2020
• Pregnancy Detection Kit Market in the US
  2015-2019
• Global Prenatal and Newborn Genetic Testing
  Market 2015-2019
• Global Knee Implant market 2015-2019
• Global Isosorbide Market 2015-2019
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Panic Disorders-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Panic Disorders-Pipeline Insights,
  2014, report provides comprehensive insights
  about pipeline drugs across this indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news